Bruker (BRKR) Change in Receivables (2010 - 2024)
Bruker's (BRKR) quarterly Change in Receivables came in at $51.3 million in Q4 2024, up 546.09% YoY from $7.9 million in Q1 2024, and up 172.87% on a QoQ basis from $18.8 million in Q3 2024.
Bruker (BRKR) Change in Receivables (2010 - 2024) Analysis & Trends
Bruker (BRKR) has 15 years of Change in Receivables data on file, last reported at $51.3 million in Q4 2024.
- Quarterly Change in Receivables rose 546.09% year-over-year to $51.3 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $40.6 million (up 4411.11% YoY) and the FY2025 annual result came in at -$54.2 million, down 233.5% from the prior year.
- Change in Receivables grew to $51.3 million in Q4 2024, from $18.8 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $51.3 million in Q4 2024 to a low of -$29.5 million in Q1 2020.
- A 5-year average of $8.2 million and a median of $600000.0 in 2021 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2021 — Change in Receivables soared 1607.69% — and 2023, when it tumbled 1210.0%.
- Tracing BRKR's Change in Receivables over 5 years: stood at -$3.9 million in 2020, then surged by 1320.51% to $47.6 million in 2021, then tumbled by 40.76% to $28.2 million in 2022, then plunged by 140.78% to -$11.5 million in 2023, then soared by 546.09% to $51.3 million in 2024.
- The last three Change in Receivables figures came in at $51.3 million (Q4 2024), $18.8 million (Q3 2024), and -$13.9 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Bruker | 9.13 Bn | 9.13 Bn | 416.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 51.30 Mn |
| Dec 31, 2024 | 51.30 Mn |
| Sep 30, 2024 | 18.80 Mn |
| Sep 30, 2024 | 18.80 Mn |
| Jun 30, 2024 | -13.90 Mn |
| Jun 30, 2024 | -13.90 Mn |
| Mar 31, 2024 | -15.60 Mn |
| Mar 31, 2024 | -15.60 Mn |
| Dec 31, 2023 | -11.50 Mn |
| Dec 31, 2023 | -11.50 Mn |
| Sep 30, 2023 | 42.90 Mn |
| Sep 30, 2023 | 42.90 Mn |
| Jun 30, 2023 | -22.20 Mn |
| Jun 30, 2023 | -22.20 Mn |
| Mar 31, 2023 | -8.30 Mn |
| Mar 31, 2023 | -8.30 Mn |
| Dec 31, 2022 | 28.20 Mn |
| Dec 31, 2022 | 28.20 Mn |
| Sep 30, 2022 | 35.30 Mn |
| Sep 30, 2022 | 35.30 Mn |